Table 3.
Overall (N=14) | Dose Level 1 (N=8) | Dose Level 2 (N=6) | |
---|---|---|---|
Number cycles received, median(range) | 2 (1,5) | 2 (2,5) | 3 (1,4) |
Follow-up Status | |||
Alive | 9 (64.3%) | 5 (62.5%) | 4 (66.7%) |
Dead | 5 (35.7%) | 3 (37.5%) | 2 (33.3%) |
Progression Status | |||
Yes | 10 (71.4%) | 7 (87.5%) | 3 (50%) |
No | 4 (28.6%) | 1 (12.5%) | 3 (50%) |
Off Active Treatment | |||
Yes | 14 (100%) | 8 (100%) | 6 (100%) |
Reason End Treatment | |||
Progression Onstudy | 10 (71.4%) | 7 (87.5%) | 3 (50%) |
Refused Further Rx | 1 (7.1%) | 1 (12.5%) | 0 (0%) |
AEs/Side Effects | 3 (21.4%) | 0 (0%) | 3 (50%) |